Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 – Trademark Portfolio
Entity Type: 99
Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. The owner is based in Dallas, TX.
Suite 014
8210 Walnut Hill Lane
Dallas, TX 75231
Showing of trademarks Trademarks
Trademark Classifications
Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 have?
Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 has 1 U.S. trademark filed with the USPTO.
What trademark classes does Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 file in?
Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What is Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231's trademark registration success rate?
Urology Research and Education Foundation Inc , A 501c3 8210 Walnut Hill Ln, Suite 014 Dallas, Texas 75231 has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.